68 Ga-DOTATATE Measurements Predict Progression of Aortic Valve Calcification in Humans
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025
DOI: 10.1161/atvbaha.125.322779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Wesam Aldosoky und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Imaging Research Center, Radiology Department (W.A., S.A., G.G., S.S.G., I.Q., E.H., O.A., J.B., G.C., M.T.O., A.T.), Massachusetts Ge…. Hauptthemen laut MEDLINE: Aortic Valve, Positron Emission Tomography Computed Tomography, Calcinosis, Organometallic Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Inflammation potentiates aortic valve calcification (AVC). 68 Ga-DOTATATE (gallium-68 DOTA-(Tyr³)-octreotate), a positron emission tomography tracer that binds to somatostatin receptors, provides a measure of tissue inflammation. However, the diagnostic and prognostic values of aortic valve (AV) 68 Ga-DOTATATE uptake in AVC remain unexplored. Here, we tested whether AV 68 Ga-DOTATATE uptake predicts the progression of AVC. METHODS: A total of 683 individuals (median age, 63 years; 46% male) underwent clinical 68 Ga-DOTATATE positron emission tomography/computed tomography imaging from 2017 to 2023; 209 had follow-up imaging (median, 1.3 years interval). AV inflammation was measured as the maximum standardized uptake value of 68 Ga-DOTATATE uptake within the AV on baseline positron emission tomography/computed tomography. AVC was quantified on baseline and follow-up computed tomography scans (Hounsfield units >130). AVC progression was assessed as the difference between baseline and follow-up AVC. Individuals with a square root difference of annualized AVC change ≥2.5 were characterized as progressors and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Imaging Research Center, Radiology Department (W.A., S.A., G.G., S.S.G., I.Q., E.H., O.A., J.B., G.C., M.T.O., A.T.), Massachusetts General Hospital and Harvard Medical School, Boston.
- Cardiology Division (S.A., S.S.G., I.Q., M.T.O., A.T.), Massachusetts General Hospital and Harvard Medical School, Boston.
- Department of Radiology, Massachusetts General Hospital, Boston (S.A., P.H.).
- Vascular Medicine Department, Georges Pompidou University Hospital, APHP, Université Paris Cité, Paris, France (G.G.).
- Center for Cardiovascular Science, Cardiology Department, University of Edinburgh, United Kingdom (M.R.D.).
ORCID-Profile: Wesam Aldosoky, Shady Abohashem, Guillaume Goudot, Simran S Grewal, Omar Alani, Jamie Bellinge, Giovanni Civieri, Michael T Osborne, Marc R Dweck, Pedram Heidari, Ahmed Tawakol
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Aldosoky, W., Abohashem, S., Goudot, G., Grewal, S. S., Qamar, I., Hanlon, E., Alani, O., Bellinge, J., Civieri, G., Osborne, M. T., Dweck, M. R., Heidari, P., & Tawakol, A. (2025). 68 Ga-DOTATATE Measurements Predict Progression of Aortic Valve Calcification in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.322779
Vancouver
Aldosoky W, Abohashem S, Goudot G, Grewal SS, Qamar I, Hanlon E, et al. 68 Ga-DOTATATE Measurements Predict Progression of Aortic Valve Calcification in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.125.322779
BibTeX
@article{Aldosoky2025,
author = {Aldosoky, Wesam and Abohashem, Shady and Goudot, Guillaume and Grewal, Simran S and Qamar, Iqra and Hanlon, Erin and Alani, Omar and Bellinge, Jamie and Civieri, Giovanni and Osborne, Michael T and Dweck, Marc R and Heidari, Pedram and Tawakol, Ahmed},
title = {68 Ga-DOTATATE Measurements Predict Progression of Aortic Valve Calcification in Humans},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
doi = {10.1161/atvbaha.125.322779}
}
EUVIMED